Journal article · 2023

Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer

Ishani Paul, Alankar Roy, Sujay Ray

Chemistry & Biodiversity, 20(12), e202300806 · Published 1 December 2023 · DOI 10.1002/cbdv.202300806

View at the publisherCite this paper

In brief

“Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer” is a 2023 journal article by Ishani Paul and 2 co-authors, published in Chemistry & Biodiversity. OpenAlex counts 4 citations as of 21 November 2026, which puts it in the top 8% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
4
Most cited in
2024 (2)
Field-weighted impact
0.31
References
81
Authors
3

Abstract

The IL‐6/IL‐6R/gp130 complex serves as a significant indicator of cytokine release syndrome in COVID‐19 and chronic inflammation, increasing the risk of cancer. Therefore, we identified IL‐6Rα as a potential target to block gp130 interaction. Notably, there has been no reception of approval for an orally available drug to serve this purpose, to date. In this… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Paul, I., Roy, A., & Ray, S. (2023). Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer. Chemistry & Biodiversity, 20(12), e202300806. https://doi.org/10.1002/cbdv.202300806

MLA 9

Paul, Ishani, et al. “Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer.” Chemistry & Biodiversity, vol. 20, no. 12, 2023, p. e202300806. https://doi.org/10.1002/cbdv.202300806.

Chicago

Paul, Ishani, Alankar Roy, and Sujay Ray. 2023. “Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer.” Chemistry & Biodiversity 20 (12): e202300806. https://doi.org/10.1002/cbdv.202300806.

Harvard

Paul, I., Roy, A. and Ray, S. (2023) ‘Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer’, Chemistry & Biodiversity, 20(12), p. e202300806. doi:10.1002/cbdv.202300806.

IEEE

I. Paul, A. Roy, and S. Ray, “Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer,” Chemistry & Biodiversity, vol. 20, no. 12, p. e202300806, 2023, doi: 10.1002/cbdv.202300806.

BibTeX

@article{paul2023molecular,
  title     = {{Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer}},
  author    = {Paul, Ishani and Roy, Alankar and Ray, Sujay},
  journal   = {Chemistry \& Biodiversity},
  year      = {2023},
  volume    = {20},
  number    = {12},
  pages     = {e202300806},
  doi       = {10.1002/cbdv.202300806},
  url       = {https://doi.org/10.1002/cbdv.202300806}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • IL-6 receptor alpha
  • gp130
  • cytokine release syndrome
  • COVID-19 pandemic
  • cancer
  • pharmacophore modeling
  • scaffold hopping
  • phytochemicals

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Paul, I., Roy, A., & Ray, S. (2023). Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer. Chemistry & Biodiversity, 20(12), e202300806. https://doi.org/10.1002/cbdv.202300806

How many times has this paper been cited?

4 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Ishani Paul, Alankar Roy, Sujay Ray.

What is the DOI of this paper?

10.1002/cbdv.202300806, permanently at https://doi.org/10.1002/cbdv.202300806. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.